Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial

BACKGROUND: Approximately 180 million people worldwide, (3 % of the world’s population) are infected with hepatitis C (HCV). Insulin resistance (IR) and type 2 diabetes (T2DM) are common extrahepatic manifestations of chronic HCV infection and associated with poor treatment and liver-related outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Doyle, Mary-Anne, Singer, Joel, Lee, Terry, Muir, Miriam, Cooper, Curtis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955144/
https://www.ncbi.nlm.nih.gov/pubmed/27439433
http://dx.doi.org/10.1186/s13063-016-1454-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955144/
https://www.ncbi.nlm.nih.gov/pubmed/27439433
http://dx.doi.org/10.1186/s13063-016-1454-6

Ejemplares similares